Cerity Partners LLC Caribou Biosciences, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 40,722 shares of CRBU stock, worth $35,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,722
Previous 15,451
163.56%
Holding current value
$35,020
Previous $24,000
54.17%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRBU
# of Institutions
142Shares Held
53.7MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$5.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$3.89 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$3.33 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$2.36 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$2.15 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $52.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...